We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$513M
AUM Growth
-$74.9M
Cap. Flow
-$71.4M
Cap. Flow %
-13.92%
Top 10 Hldgs %
16.18%
Holding
249
New
34
Increased
44
Reduced
101
Closed
55

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.87M
2
MGY icon
Magnolia Oil & Gas
MGY
+$6.85M
3
TDW icon
Tidewater
TDW
+$6.69M
4
CADE
Cadence Bank
CADE
+$6.45M
5
COCO icon
Vita Coco
COCO
+$5.32M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$9.45M
2
CNS icon
Cohen & Steers
CNS
+$9.41M
3
BWXT icon
BWX Technologies
BWXT
+$8.27M
4
STAG icon
STAG Industrial
STAG
+$6.59M
5
PR
Permian Resources
PR
+$6.56M

Sector Composition

Rank Sector Weight
1 Healthcare 17.37%
2 Industrials 16.17%
3 Financials 14.84%
4 Consumer Discretionary 13.64%
5 Technology 13.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEIS icon
51
Advanced Energy
AEIS
$13B
$4.51M 0.88%
41,496
+21,833
+111% +$2.24M
EPAC icon
52
Enerpac Tool Group
EPAC
$1.93B
$4.46M 0.87%
+116,807
New +$4.33M
CSW
53
CSW Industrials
CSW
$5.71B
$4.45M 0.87%
+16,784
New +$4.16M
HGV icon
54
Hilton Grand Vacations
HGV
$3.55B
$4.44M 0.86%
109,729
+3,591
+3% +$152K
CPRX
55
DELISTED
Catalyst Pharmaceutical
CPRX
$4.37M 0.85%
282,074
-18,877
-6% -$294K
VRNA
56
DELISTED
Verona Pharma
VRNA
$4.28M 0.83%
295,945
-18,967
-6% -$277K
NAMS icon
57
NewAmsterdam Pharma
NAMS
$3.34B
$4.24M 0.83%
220,667
+109,400
+98% +$2.19M
OSIS icon
58
OSI Systems
OSIS
$3.89B
$4.16M 0.81%
+30,221
New +$4.17M
ITRI icon
59
Itron
ITRI
$4.54B
$4.04M 0.79%
+40,843
New +$4.11M
ATKR icon
60
Atkore
ATKR
$3.16B
$3.97M 0.77%
29,415
-1,973
-6% -$314K
TMDX icon
61
Transmedics
TMDX
$2.91B
$3.94M 0.77%
26,181
-8,349
-24% -$1M
BRBR icon
62
BellRing Brands
BRBR
$1.34B
$3.91M 0.76%
68,365
-4,289
-6% -$246K
CYTK icon
63
Cytokinetics
CYTK
$10.4B
$3.79M 0.74%
69,905
-2,992
-4% -$181K
AZEK
64
DELISTED
The AZEK Co
AZEK
$3.69M 0.72%
87,592
+10,186
+13% +$471K
ARCB icon
65
ArcBest
ARCB
$3.08B
$3.64M 0.71%
34,015
-2,165
-6% -$261K
NOVT icon
66
Novanta
NOVT
$5.92B
$3.61M 0.7%
22,116
+1,767
+9% +$287K
SSD icon
67
Simpson Manufacturing
SSD
$8.16B
$3.55M 0.69%
21,043
-1,422
-6% -$249K
SMPL icon
68
Simply Good Foods
SMPL
$982M
$3.52M 0.69%
97,370
-124,426
-56% -$4.45M
WD icon
69
Walker & Dunlop
WD
$1.53B
$3.43M 0.67%
34,915
-14,478
-29% -$1.38M
NSSC icon
70
Napco Security Technologies
NSSC
$1.48B
$3.39M 0.66%
+65,187
New +$2.98M
AIN icon
71
Albany International
AIN
$1.78B
$3.38M 0.66%
40,069
-21,205
-35% -$1.85M
SKWD icon
72
Skyward Specialty Insurance
SKWD
$2.58B
$3.36M 0.65%
92,787
-114,893
-55% -$4.17M
ACLS icon
73
Axcelis
ACLS
$4.31B
$3.35M 0.65%
+23,582
New +$2.72M
OXM icon
74
Oxford Industries
OXM
$552M
$3.33M 0.65%
33,250
-2,243
-6% -$236K
IPAR icon
75
Interparfums
IPAR
$3.94B
$3.29M 0.64%
+28,383
New +$3.45M
1 2
3
4 5

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Moody Aldrich Partners held 249 positions worth $513M, down 13% from $588M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Moody Aldrich Partners withdrew a net $71.4M in Q2 2024, closing 55 positions and reducing 101 holdings. Its most notable exit was Cohen & Steers, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Moody Aldrich Partners opened a new position in Intra-Cellular Therapies Inc. worth $6.78M.

  • Moody Aldrich Partners's largest Q2 2024 buy was Intra-Cellular Therapies Inc.: 99,012 shares worth $6.78M.
  • Moody Aldrich Partners added most to Crinetics Pharmaceuticals in Q2 2024, an estimated $4.33M increase.
  • Moody Aldrich Partners's biggest Q2 2024 reduction was SharkNinja, cutting an estimated $9.45M.
  • Moody Aldrich Partners fully exited Cohen & Steers in Q2 2024, selling an estimated $9.41M.
  • Moody Aldrich Partners's ten largest holdings make up 16% of its $513M portfolio in Q2 2024.
  • Moody Aldrich Partners opened 34 new positions and closed 55 in Q2 2024.
  • Moody Aldrich Partners's portfolio value fell 13% quarter-over-quarter to $513M.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.